Christopher Abbosh

10.5k total citations · 1 hit paper
6 papers, 1.6k citations indexed

About

Christopher Abbosh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Christopher Abbosh has authored 6 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Christopher Abbosh's work include Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Christopher Abbosh is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Christopher Abbosh collaborates with scholars based in United Kingdom, United States and Canada. Christopher Abbosh's co-authors include Charles Swanton, Nicolai J. Birkbak, Raymond H. Mak, Alireza Mehrtash, Omar Arnaout, Ian F. Dunn, Wenya Linda Bi, Matthew B. Schabath, Udo Hoffmann and Robert J. Gillies and has published in prestigious journals such as Nature, CA A Cancer Journal for Clinicians and Nature Reviews Clinical Oncology.

In The Last Decade

Christopher Abbosh

5 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Artificial intelligence in cancer imaging: Clinical challenges and applications

2019 1.2k citations Wenya Linda Bi, Ahmed Hosny et al. CA A Cancer Journal for Clinicians profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Abbosh United Kingdom	5	864	555	339	339	333	6	1.6k
Enrico Cassano Italy	31	1.0k 1.2×	463 0.8×	446 1.3×	820 2.4×	499 1.5×	149	2.5k
Michele Avanzo Italy	22	1.3k 1.5×	719 1.3×	253 0.7×	138 0.4×	253 0.8×	63	1.8k
Jonathan J. James United Kingdom	23	613 0.7×	636 1.1×	522 1.5×	532 1.6×	700 2.1×	67	1.8k
Meiyun Wang China	21	1.7k 1.9×	481 0.9×	422 1.2×	270 0.8×	392 1.2×	52	2.6k
Lynn Jeanette Savic Germany	22	780 0.9×	296 0.5×	229 0.7×	216 0.6×	309 0.9×	62	1.6k
Yongbei Zhu China	14	1.2k 1.4×	559 1.0×	418 1.2×	105 0.3×	320 1.0×	25	1.5k
Nathaniel Braman United States	9	1.5k 1.7×	496 0.9×	349 1.0×	166 0.5×	282 0.8×	22	1.6k
Maria Vakalopoulou France	12	1.1k 1.2×	501 0.9×	223 0.7×	95 0.3×	432 1.3×	30	1.5k
William T. Tran Canada	27	1.1k 1.2×	302 0.5×	486 1.4×	301 0.9×	315 0.9×	86	1.9k
Margarita Kirienko Italy	28	1.8k 2.0×	913 1.6×	255 0.8×	170 0.5×	489 1.5×	69	2.3k

Countries citing papers authored by Christopher Abbosh

Since Specialization

Citations

This map shows the geographic impact of Christopher Abbosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Abbosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Abbosh more than expected).

Fields of papers citing papers by Christopher Abbosh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Abbosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Abbosh. The network helps show where Christopher Abbosh may publish in the future.

Co-authorship network of co-authors of Christopher Abbosh

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Abbosh. A scholar is included among the top collaborators of Christopher Abbosh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Abbosh. Christopher Abbosh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Pai, S. P., Jiachen Chen, Asya Lyass, et al.. (2026). Thymic health consequences in adults. Nature.

2.

Peters, S., David R. Spigel, Myung‐Ju Ahn, et al.. (2021). P03.03 MERMAID-1: A Phase III Study of Adjuvant Durvalumab plus Chemotherapy in Resected NSCLC Patients with MRD+ Post-Surgery. Journal of Thoracic Oncology. 16(3). S258–S259. 36 indexed citations

3.

Spigel, David R., Solange Peters, M-J. Ahn, et al.. (2021). 93TiP MERMAID-2: Phase III study of durvalumab in patients with resected, stage II-III NSCLC who become MRD+ after curative-intent therapy. Journal of Thoracic Oncology. 16(4). S745–S746. 38 indexed citations

4.

Bi, Wenya Linda, Ahmed Hosny, Matthew B. Schabath, et al.. (2019). Artificial intelligence in cancer imaging: Clinical challenges and applications. CA A Cancer Journal for Clinicians. 69(2). 127–157. 1199 indexed citations breakdown →

5.

Abbosh, Christopher, Nicolai J. Birkbak, & Charles Swanton. (2018). Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection. Nature Reviews Clinical Oncology. 15(9). 577–586. 276 indexed citations

6.

Abbosh, Christopher, Subramanian Venkatesan, Sam M. Janes, Rebecca C. Fitzgerald, & Charles Swanton. (2017). Evolutionary dynamics in pre-invasive neoplasia. Current Opinion in Systems Biology. 2. 1–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact